Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

D2 be or not to be?

Neuroimaging of monozygotic twins with Tourette syndrome suggests that increased binding by dopamine D2 receptors contributes to the disease phenotype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Robertson, M.M. Annotation: Gilles de la Tourette syndrome — an update. J. Child Psychol. Psychiatry 35, 597–611 (1994).

    Article  CAS  Google Scholar 

  2. Wolf, S.S. et al. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273, 1225–1227 (1996).

    Article  CAS  Google Scholar 

  3. Heutink, P. et al. Progress in gene localization. in Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. (ed. Kurlan, R.) 317–335 (Marcel Dekker, New York, 1993).

    Google Scholar 

  4. Nothen, M.M. et al. Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method. Am. J. Med. Genet. 54, 249–252 (1994).

    Article  CAS  Google Scholar 

  5. Gerlernter, J. et al. D2 dopamine receptor alleles do not influence severity of Tourette's syndrome: Results from four large kindreds. Arch. Neurol. 51, 397–400 (1994).

    Article  Google Scholar 

  6. Leckman, J.F. et al. Non-genetic factors in Gilles de la Tourette syndrome [Letter to the Editor]. Arch. Gen. Psychiatry. 44, 100 (1987).

    Article  CAS  Google Scholar 

  7. Moriarty, J. et al. Brain perfusion abnormalities in Gilles de la Tourette's syndrome. Br. J. Psychiatry 167, 249–254 (1995).

    Article  CAS  Google Scholar 

  8. Wong, D.F. et al. Dopamine transporter reuptake sites measured by [C11] WIN 35, 428 PET imaging are elevated in Tourette syndrome patients. J. Nucl. Med. 130P (No 524) (1994).

  9. Malison, R.T. et al. [123I] β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am. J. Psychiatry 152, 1359–1361 (1995).

    Article  CAS  Google Scholar 

  10. Turjanski, N. et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J. Neurol. Neurosurg. Psychiatry 57, 688–692 (1994).

    Article  CAS  Google Scholar 

  11. George, M.S. et al. Dopamine receptor availability in Tourette's syndrome. Psychiatry Res. 55, 193–203 (1994).

    Article  CAS  Google Scholar 

  12. Singer, H.S. Neurochemical analysis of postmortem cortical and striatal brain tissue in patients with Tourette syndrome. Adv. Neurol. 58, 135–144 (1992).

    CAS  PubMed  Google Scholar 

  13. Pilowsky, L.S. et al. D2 Dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients: An 123I-IBZM single photon emission computed tomography study. Br. J. Psychiatry 164, 16–26 (1994).

    Article  CAS  Google Scholar 

  14. Peterson, B. et al. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology 43, 941–949 (1993).

    Article  CAS  Google Scholar 

  15. Hyde, T.M. et al. Cerebral morphometric abnormalities in Tourette's syndrome: A quantitative MRI study of monozygotic twins. Neurology 45, 1176–1182 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robertson, M. D2 be or not to be?. Nat Med 2, 1076–1077 (1996). https://doi.org/10.1038/nm1096-1076

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1096-1076

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing